[ad_1]
According to the Norwegian Medicines Agency, autopsies of 13 dead people studied so far have shown that the most common side effects of the vaccine may have been seen in frail older people.
“Even the relatively mild side effects of the vaccine can have serious consequences for the terminally ill, the weakest patients,” wrote bloomberg.com, citing the Norwegian Institute of Public Health.
It is added that the benefit of the vaccine may be less significant in those patients whose life expectancy is still short. However, it is emphasized that this should in no way be a recommendation for younger and healthier people to avoid vaccination.
At the same time, it should be borne in mind that this is one of the first signs that countries need to start constant monitoring of vaccine safety.
“Emer Cooke, the new director of the European Medicines Agency, said that monitoring the safety of Covid-19 vaccines, especially those based on new technologies such as mRNA, will be a great challenge,” the article said.
In Norway, some 33,000 people have so far been vaccinated with at least one dose. people, prioritizing those most at risk of contracting the virus, including the elderly. Most of the injected doses are from Pfizer-BioNTech. Vaccination with the Moderna vaccine has also been launched.
Both Covid-19 vaccines, which have been approved in Europe to date, have been tested in tens of thousands of people, including volunteers between the ages of 80 and 90, with an average age of 50 years.
To date, allergic reactions to vaccines have not been common. US authorities reported 21 cases of severe allergic reactions between December 14 and 23 after the administration of approximately 1.9 million first doses of the Pfizer vaccine.
At that time in France, a weak patient died in a nursing home two hours after vaccination. However, authorities said that based on the patient’s previous medical history, there was no indication that the death was related to the vaccine. The French Agency for Pharmaceutical Safety on Thursday reported four cases of serious allergic reactions and two cases of heart rhythm disorders after vaccination.
The portal recalls that the Pfizer-BioNTech vaccine, approved at the end of last year, has so far been the most widely used in Europe. The second modern vaccine has recently been approved by the EU.
[ad_2]
